Insmed, Inc. (INSM)
160.02
+3.70
(+2.36%)
USD |
NASDAQ |
Jan 22, 14:38
Insmed Research and Development Expense (TTM): 695.91M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.248B |
| Biogen, Inc. | 1.524B |
| CorMedix, Inc. | 12.46M |
| Merck & Co., Inc. | 14.26B |
| Pfizer Inc. | 10.13B |